Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis
Frontiers in Pharmacology · 20.03.2023 · 14
DOI: 10.3389/fphar.2023.1027277 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.03.2023. Verfasst von Hossein Nateghizad und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Faculty of Basic Sciences, East of Tehran Branch, Islamic Azad University, Tehran, Iran. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Cholera is a challenging ancient disease caused by Vibrio cholera ( V. cholera) . Antibiotics that prevent cell wall synthesis are among the first known antibiotic groups. Due to its high consumption, V. cholera has developed resistance to the majority of antibiotics in this class. Resistance to recommended antibiotics for the treatment of V. cholera has also increased. In light of the decrease in consumption of certain antibiotics in this group that inhibit cell wall synthesis and the implementation of new antibiotics, it is necessary to determine the antibiotic resistance pattern of V. cholera and to employ the most effective treatment antibiotic.
Method
An comprehensive systematic search for relevant articles was conducted in PubMed, Web of Science, Scopus, and EMBASE through October 2020. Stata version 17.1 utilized the Metaprop package to execute a Freeman-Tukey double arcsine transformation in order to estimate weighted pooled proportions.
Results
A total of 131 articles were included in the meta-analysis. Ampicillin was the most investigated antibiotic. The prevalence of antibiotic resistance was in order aztreonam (0%), cefepime (0%), imipenem (0%), meropenem (3%), fosfomycin (4%), ceftazidime (5%), cephalothin (7%), augmentin (8%), cefalexin (8%), ceftriaxone (9%), cefuroxime (9%), cefotaxime (15%), cefixime (37%), amoxicillin (42%), penicillin (44%), ampicillin (48%), cefoxitin (50%), cefamandole (56%), polymyxin-B (77%), carbenicillin (95%) respectively.
Discussion
Aztreonam, cefepime, and imipenem are the most efficient V. cholera cell wall synthesis inhibitors. There has been an increase in resistance to antibiotics such as cephalothin, ceftriaxone, amoxicillin, and meropenem. Over the years, resistance to penicillin, ceftazidime, and cefotaxime, has decreased.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, Faculty of Basic Sciences, East of Tehran Branch, Islamic Azad University, Tehran, Iran.
- Department of Microbiology, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Veterinary medicine, Science and Research Branch, Islamic Azad University, Tehran, Iran.
- Department Of Veterinary, Azad University Of Shahr-E Kord, Shahrekord, Iran.
- Department of Microbiology, Saveh Branch, Islamic Azad University, Saveh, Iran.
Zitieren
APA
Nateghizad, H., Sajadi, R., Shivaee, A., Shirazi, O., Sharifian, M., Tadi, D. A., & Amini, K. (2023). Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1027277
Vancouver
Nateghizad H, Sajadi R, Shivaee A, Shirazi O, Sharifian M, Tadi DA, et al. Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1027277
BibTeX
@article{Nateghizad2023,
author = {Nateghizad, Hossein and Sajadi, Rojina and Shivaee, Ali and Shirazi, Omid and Sharifian, Mohadeseh and Tadi, Danyal Abbasi and Amini, Kumarss},
title = {Resistance of Vibrio cholera to antibiotics that inhibit cell wall synthesis: A systematic review and meta-analysis},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1027277}
}
EUVIMED